Andrew I. Bell

Overview

Best Publications

• Epstein–Barr virus-associated lymphomas

  Claire Shannon-Lowe;Alan B. Rickinson;Andrew I. Bell

  412
  Citations

• Stringent spacing requirements for transcription activation by CRP.

  Kevin Gaston;Andrew Bell;Annie Kolb;Henri Buc

  327
  Citations

• Epstein–Barr virus–associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2

  Gemma Kelly;Andrew Bell;Alan Rickinson

  316
  Citations

• Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription

  Andrew Bell;Kevin Gaston;Roy Williams;Karen Chapman

  238
  Citations

• An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.

  Gemma L. Kelly;Heather M. Long;Julianna Stylianou;Wendy A. Thomas

  230
  Citations

• Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.

  Carol Nonkwelo;Julia Skinner;Andrew Bell;Alan Rickinson

  205
  Citations

• Three restricted forms of Epstein–Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells

  Gemma L. Kelly;Anne E. Milner;Gouri S. Baldwin;Andrew I. Bell

  199
  Citations

• Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma

  Judith M. Timms;Andrew Bell;Joanne R. Flavell;Paul G. Murray

  196
  Citations

• Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.

  Fiona Nitsche;Andrew Bell;Alan Rickinson

  187
  Citations

• Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.

  Andrew I. Bell;Katherine Groves;Gemma L. Kelly;Debbie Croom-Carter

  178
  Citations

• Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification

  Claire Shannon-Lowe;Emily Adland;Andrew I. Bell;Henri Jacques Delecluse

  169
  Citations

• Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

  Gemma L. Kelly;Anne E. Milner;Rosemary J. Tierney;Debbie S. G. Croom-Carter

  155
  Citations

• Tonsillar homing of Epstein-Barr virus-specific CD8(+) T cells and the virus-host balance

  Andrew D. Hislop;Michael Kuo;Adrian B. Drake-Lee;Arne N. Akbar

  151
  Citations

• Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology

  Martin Rowe;Gemma L. Kelly;Andrew I. Bell;Alan B. Rickinson

  142
  Citations

• Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt’s Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas

  G. Habeshaw;Q. Y. Yao;A. I. Bell;D. Morton

  136
  Citations

• The functional subunit of a dimeric transcription activator protein depends on promoter architecture

  Yuhong Zhou;P. S. Pendergrast;A. Bell;R. Williams

  131
  Citations

• Quantitative Studies of Epstein-Barr Virus-Encoded MicroRNAs Provide Novel Insights into Their Regulation

  Richard Amoroso;Leah Fitzsimmons;Wendy A Thomas;Gemma L Kelly

  131
  Citations

• Cloning of binding sequences for the Escherichia coli transcription activators, FNR and CRP: location of bases involved in discrimination between FNR and CRP.

  A.I. Bell;K.L. Gaston;J.A. Cole;S.J.W. Busby

  127
  Citations

• The Effects of Acute Malaria on Epstein-Barr Virus (EBV) Load and EBV-Specific T Cell Immunity in Gambian Children

  Ramou Njie;Andrew I. Bell;Hui Jia;Debbie Croom-Carter

  127
  Citations

• Epstein-Barr virus and Burkitt lymphoma.

  Martin Rowe;Leah Fitzsimmons;Andrew I Bell

  84
  Citations